Modified gateway system for double shRNA expression and Cre/lox based gene expression

BMC Biotechnology

Volumn 11, Issue , 2011, Pages

  Radulovich, Nikolina ^a,b   Leung, Lisa ^a   Tsao, Ming Sound ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CMV PROMOTER; EXPRESSION SYSTEM; EXPRESSION VECTORS; GATEWAY SYSTEM; GENE FUNCTION; GENE OVER-EXPRESSION; GREEN FLUORESCENT PROTEIN; HIGH-THROUGHPUT ANALYSIS; HYGROMYCIN; LENTIVIRAL EXPRESSION; MARKER GENES; MULTIPLE CLONING; PROOF OF PRINCIPLES; RED FLUORESCENT PROTEINS; SHORT HAIRPIN RNA (SHRNA); VERSATILE TOOLS; YELLOW FLUORESCENT PROTEINS;

CLONING; FLUORESCENCE; PROTEINS; RNA; VECTORS;

GENE EXPRESSION;

COMPLEMENTARY DNA; CRE RECOMBINASE; ENHANCED GREEN FLUORESCENT PROTEIN; HYGROMYCIN; LENTIVIRUS VECTOR; PROTEIN LYSINE 6 OXIDASE; PUROMYCIN; RED FLUORESCENT PROTEIN; SHORT HAIRPIN RNA; YELLOW FLUORESCENT PROTEIN; INTEGRASE; SMALL INTERFERING RNA;

ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA SEQUENCE; EXPRESSION VECTOR; GENE EXPRESSION; GENE EXPRESSION SYSTEM; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC RECOMBINATION; GENETIC SELECTION; HUMAN; HUMAN CELL; LOXP SITE; MARKER GENE; MOLECULAR CLONING; PROMOTER REGION; RNA SEQUENCE; RNA VECTOR; CELL LINE; EVALUATION; GENE TARGETING; GENE VECTOR; GENETICS; INSTRUMENTATION; METABOLISM; METHODOLOGY;

HELICOBACTER HEILMANNII TYPE 1;

CELL LINE; GENE EXPRESSION; GENE TARGETING; GENETIC VECTORS; HUMANS; INTEGRASES; RECOMBINATION, GENETIC; RNA, SMALL INTERFERING;

EID: 79953080436     PISSN: None     EISSN: 14726750     Source Type: Journal    
DOI: 10.1186/1472-6750-11-24     Document Type: Article

References (39)

1. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411(6836):494-498. 10.1038/35078107, 11373684.
2. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002, 296(5567):550-553. 10.1126/science.1068999, 11910072.
3. Paddison PJ, Caudy AA, Bernstein E, Hannon GJ, Conklin DS. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 2002, 16(8):948-958. 10.1101/gad.981002, 152352, 11959843.
4. Bernards R, Brummelkamp TR, Beijersbergen RL. shRNA libraries and their use in cancer genetics. Nat Methods 2006, 3(9):701-706. 10.1038/nmeth921, 16929315.
5. Root DE, Hacohen N, Hahn WC, Lander ES, Sabatini DM. Genome-scale loss-of-function screening with a lentiviral RNAi library. Nat Methods 2006, 3(9):715-719. 10.1038/nmeth924, 16929317.
6. Moffat J, Grueneberg DA, Yang X, Kim SY, Kloepfer AM, Hinkle G, Piqani B, Eisenhaure TM, Luo B, Grenier JK, Carpenter AE, Foo SY, Stewart SA, Stockwell BR, Hacohen N, Hahn WC, Lander ES, Sabatini DM, Root DE. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 2006, 124(6):1283-1298. 10.1016/j.cell.2006.01.040, 16564017.
7. Freuler F, Stettler T, Meyerhofer M, Leder L, Mayr LM. Development of a novel Gateway-based vector system for efficient, multiparallel protein expression in Escherichia coli. Protein Expr Purif 2008, 59(2):232-241. 10.1016/j.pep.2008.02.003, 18375142.
8. Fux C, Langer D, Kelm JM, Weber W, Fussenegger M. New-generation multicistronic expression platform: pTRIDENT vectors containing size-optimized IRES elements enable homing endonuclease-based cistron swapping into lentiviral expression vectors. Biotechnol Bioeng 2004, 86(2):174-187. 10.1002/bit.20028, 15052637.
9. Greber D, Fussenegger M. Multi-gene engineering: simultaneous expression and knockdown of six genes off a single platform. Biotechnol Bioeng 2007, 96(5):821-834. 10.1002/bit.21303, 17163510.
10. Magnani E, Bartling L, Hake S. From Gateway to MultiSite Gateway in one recombination event. BMC Mol Biol 2006, 7:46. 10.1186/1471-2199-7-46, 1702363, 17150110.
11. Mitta B, Rimann M, Ehrengruber MU, Ehrbar M, Djonov V, Kelm J, Fussenegger M. Advanced modular self-inactivating lentiviral expression vectors for multigene interventions in mammalian cells and in vivo transduction. Nucleic Acids Res 2002, 30(21):e113. 10.1093/nar/gnf112, 135834, 12409472.
12. Sasaki Y, Sone T, Yahata K, Kishine H, Hotta J, Chesnut JD, Honda T, Imamoto F. Multi-gene gateway clone design for expression of multiple heterologous genes in living cells: eukaryotic clones containing two and three ORF multi-gene cassettes expressed from a single promoter. J Biotechnol 2008, 136(34):103-112. 10.1016/j.jbiotec.2008.06.007, 18640160.
13. Scheich C, Kummel D, Soumailakakis D, Heinemann U, Bussow K. Vectors for co-expression of an unrestricted number of proteins. Nucleic Acids Res 2007, 35(6):e43. 10.1093/nar/gkm067, 1874614, 17311810.
14. Schubert S, Grunert HP, Zeichhardt H, Werk D, Erdmann VA, Kurreck J. Maintaining inhibition: siRNA double expression vectors against coxsackieviral RNAs. J Mol Biol 2005, 346(2):457-465. 10.1016/j.jmb.2004.11.074, 15670596.
15. Sone T, Yahata K, Sasaki Y, Hotta J, Kishine H, Chesnut JD, Imamoto F. Multi-gene gateway clone design for expression of multiple heterologous genes in living cells: modular construction of multiple cDNA expression elements using recombinant cloning. J Biotechnol 2008, 136(34):113-121. 10.1016/j.jbiotec.2008.06.006, 18640161.
16. ter Brake O, 't Hooft K, Liu YP, Centlivre M, von Eije KJ, Berkhout B. Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition. Mol Ther 2008, 16(3):557-564. 10.1038/sj.mt.6300382, 18180777.
17. Wang S, Shi Z, Liu W, Jules J, Feng X. Development and validation of vectors containing multiple siRNA expression cassettes for maximizing the efficiency of gene silencing. BMC Biotechnol 2006, 6:50. 10.1186/1472-6750-6-50, 1780051, 17187675.
18. Yahata K, Kishine H, Sone T, Sasaki Y, Hotta J, Chesnut JD, Okabe M, Imamoto F. Multi-gene gateway clone design for expression of multiple heterologous genes in living cells: conditional gene expression at near physiological levels. J Biotechnol 2005, 118(2):123-134. 10.1016/j.jbiotec.2005.02.020, 15961178.
19. Zhu X, Santat LA, Chang MS, Liu J, Zavzavadjian JR, Wall EA, Kivork C, Simon MI, Fraser ID. A versatile approach to multiple gene RNA interference using microRNA-based short hairpin RNAs. BMC Mol Biol 2007, 8:98. 10.1186/1471-2199-8-98, 2194719, 17971228.
20. Hartley JL, Temple GF, Brasch MA. DNA cloning using in vitro site-specific recombination. Genome Res 2000, 10(11):1788-1795. 10.1101/gr.143000, 310948, 11076863.
21. Landy A. Dynamic, structural, and regulatory aspects of lambda site-specific recombination. Annu Rev Biochem 1989, 58:913-949. 10.1146/annurev.bi.58.070189.004405, 2528323.
22. Campeau E, Ruhl VE, Rodier F, Smith CL, Rahmberg BL, Fuss JO, Campisi J, Yaswen P, Cooper PK, Kaufman PD. A versatile viral system for expression and depletion of proteins in mammalian cells. PLoS One 2009, 4(8):e6529. 10.1371/journal.pone.0006529, 2717805, 19657394.
23. Borman AM, Le Mercier P, Girard M, Kean KM. Comparison of picornaviral IRES-driven internal initiation of translation in cultured cells of different origins. Nucleic Acids Res 1997, 25(5):925-932. 10.1093/nar/25.5.925, 146526, 9023100.
24. Douin V, Bornes S, Creancier L, Rochaix P, Favre G, Prats AC, Couderc B. Use and comparison of different internal ribosomal entry sites (IRES) in tricistronic retroviral vectors. BMC Biotechnol 2004, 4:16. 10.1186/1472-6750-4-16, 514710, 15279677.
25. Hennecke M, Kwissa M, Metzger K, Oumard A, Kroger A, Schirmbeck R, Reimann J, Hauser H. Composition and arrangement of genes define the strength of IRES-driven translation in bicistronic mRNAs. Nucleic Acids Res 2001, 29(16):3327-3334. 10.1093/nar/29.16.3327, 55851, 11504870.
26. Martin P, Albagli O, Poggi MC, Boulukos KE, Pognonec P. Development of a new bicistronic retroviral vector with strong IRES activity. BMC Biotechnol 2006, 6:4. 10.1186/1472-6750-6-4, 1373653, 16409632.
27. Makinen PI, Koponen JK, Karkkainen AM, Malm TM, Pulkkinen KH, Koistinaho J, Turunen MP, Yla-Herttuala S. Stable RNA interference: comparison of U6 and H1 promoters in endothelial cells and in mouse brain. J Gene Med 2006, 8(4):433-441. 10.1002/jgm.860, 16389634.
28. Radulovich N, Pham NA, Strumpf D, Leung L, Xie W, Jurisica I, Tsao MS. Differential roles of cyclin D1 and D3 in pancreatic ductal adenocarcinoma. Mol Cancer 2010, 9:24. 10.1186/1476-4598-9-24, 2824633, 20113529.
29. Furukawa T, Duguid WP, Rosenberg L, Viallet J, Galloway DA, Tsao MS. Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16. Am J Pathol 1996, 148(6):1763-1770. 1861644, 8669463.
30. Shin JJ, Katayama T, Michaud WA, Rocco JW. Short hairpin RNA system to inhibit human p16 in squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2004, 130(1):68-73. 10.1001/archotol.130.1.68, 14732771.
31. Kumar M, Keller B, Makalou N, Sutton RE. Systematic determination of the packaging limit of lentiviral vectors. Hum Gene Ther 2001, 12(15):1893-1905. 10.1089/104303401753153947, 11589831.
32. Ni Y, Sun S, Oparaocha I, Humeau L, Davis B, Cohen R, Binder G, Chang YN, Slepushkin V, Dropulic B. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector. J Gene Med 2005, 7(6):818-834. 10.1002/jgm.726, 15693055.
33. Reiser J. Production and concentration of pseudotyped HIV-1-based gene transfer vectors. Gene Ther 2000, 7(11):910-913. 10.1038/sj.gt.3301188, 10849549.
34. Sena-Esteves M, Tebbets JC, Steffens S, Crombleholme T, Flake AW. Optimized large-scale production of high titer lentivirus vector pseudotypes. J Virol Methods 2004, 122(2):131-139. 10.1016/j.jviromet.2004.08.017, 15542136.
35. Kutner RH, Zhang XY, Reiser J. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat Protoc 2009, 4(4):495-505. 10.1038/nprot.2009.22, 19300443.
36. Urbinati F, Arumugam P, Higashimoto T, Perumbeti A, Mitts K, Xia P, Malik P. Mechanism of reduction in titers from lentivirus vectors carrying large inserts in the 3'LTR. Mol Ther 2009, 17(9):1527-1536. 10.1038/mt.2009.89, 2835256, 19384292.
37. Stewart SA, Dykxhoorn DM, Palliser D, Mizuno H, Yu EY, An DS, Sabatini DM, Chen IS, Hahn WC, Sharp PA, Weinberg RA, Novina CD. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 2003, 9(4):493-501. 10.1261/rna.2192803, 1370415, 12649500.
38. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002, 296(5567):550-553. 10.1126/science.1068999, 11910072.
39. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998, 72(11):8463-8471. 110254, 9765382.